Company Profiles

driven by the PitchBook Platform

Akinion Pharmaceuticals

Description

Operator of a drug development company focusing on the treatment of acute myeloid leukemia (AML). The company develops kinase receptor inhibitors for the treatment of acute myeloid leukemia.

2009

Founded

PRIVATE

Status

11-50

Employees

Early Stage VC

Latest Deal Type

3

Investors

Description

Operator of a drug development company focusing on the treatment of acute myeloid leukemia (AML). The company develops kinase receptor inhibitors for the treatment of acute myeloid leukemia.

Website:

www.akinion.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Karolinska Institutet Science Park Nobels väg 3 171 65 SolnaSweden +46 (0)8 524 869 65
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Akinion Pharmaceuticals's full profile, request a free trial.

Akinion Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Akinion Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
btov PartnersVenture CapitalMinority000 0000000 0000
Karolinska DevelopmentVenture CapitalMinority000 0000000 0000
Rosetta Capital(London)Venture CapitalMinority000 0000000 0000
btov Partners Venture Capital
Karolinska Development Venture Capital
Rosetta Capital(London) Venture Capital

Akinion Pharmaceuticals Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Lars Abrahmsén Ph.DVice President of Preclinical Development & Chief Scientific Officer
Kristina CarlssonDirector, Regulatory Affairs
Mikael von Euler Ph.DChief Medical Officer & Vice President, Clinical Development
Birgitta StåhlVice President & Chief Operating Officer
John MeewellaChief Executive Officer
Lars Abrahmsén Ph.D Vice President of Preclinical Development & Chief Scientific Officer
Kristina Carlsson Director, Regulatory Affairs
Mikael von Euler Ph.D Chief Medical Officer & Vice President, Clinical Development
Birgitta Ståhl Vice President & Chief Operating Officer
John Meewella Chief Executive Officer

Akinion Pharmaceuticals Board Members (4)

NameRepresentingRoleSinceContact
Info
Graham Fagg Ph.DRosetta Capital(London)Partner000 0000
Michael MooreAkinion PharmaceuticalsChairman000 0000
Stefan Fraenkel Ph.DSelfBoard Member000 0000
Viktor DrvotaAkinion PharmaceuticalsBoard Member000 0000
Graham Fagg Ph.D Partner Rosetta Capital(London)
Michael Moore Chairman Akinion Pharmaceuticals
Stefan Fraenkel Ph.D Board Member Self
Viktor Drvota Board Member Akinion Pharmaceuticals
Request full access to PitchBook